The report shows that CDNetworks' security platform intercepted 887.4 billion web attacks targeting applications and APIs in ...

Fintel reports that on May 28, 2025, Leerink Partners downgraded their outlook for Rocket Pharmaceuticals (NasdaqGM:RCKT) ...

T therapies is an expensive business. The fundamental problem is that CAR-T production is not a good fit for centralized manufacturing.

FDA places clinical hold of RP-A501 for the treatment of patients with Danon disease due to a patient death. Click here to ...

Sami Corwin, an analyst at William Blair, maintained his Outperform rating on Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) on ...

Wacker and Expression Manufacturing want to offer clients with an end-to-end, optimized solution for viral vector development and production.

TransCode Therapeutics, Inc. , a clinical-stage oncology company developing RNA-targeted therapeutics for the treatment of cancer, today announced the appointment of Phillip D. Zamore, Ph.D., to its ...

Fintel reports that on May 28, 2025, Jefferies downgraded their outlook for Rocket Pharmaceuticals (NasdaqGM:RCKT) from Buy ...

Dengue Vaccines Market Projected to Grow from USD 90 Million in 2025 to Nearly USD 200 Million by 2035The global Dengue Vaccines Market is expected to be reach USD 90.0 million in 2025 and is likely ...

Rocket Pharmaceuticals, Inc. , a fully integrated, late-stage biotechnology company advancing an integrated pipeline of genetic therapies for rare diseases, today announced an update related to ...

The report also highlights a rise in both the intensity and sophistication of attacks, fueled by the rapid adoption of AI ...